A similar trend was found for DDIT4 expression in the HCC group (6.62 ± 4.48) when compared with the non-HCC group (0.16 ± 3.42, P < 0.001) and healthy controls (0.00 ± 3.37, P < 0.001). Here, DDIT4 is linked to hepatocellular carcinoma.